Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography

INTRODUCTION: We evaluated various morphological and molecular response criteria in metastatic castration-resistant prostate cancer (PCa) patient undergoing peptide receptor radioligand therapy (PRLT) with Lutetium177-prostate-specific membrane antigen (PSMA) by using Gallium 68-PSMA positron-emissi...

Descripción completa

Detalles Bibliográficos

Autores principales:	Gupta, Manoj, Choudhury, Partha Sarathi, Rawal, Sudhir, Goel, Harish Chandra, Rao, Shriram Avinash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476211/ https://www.ncbi.nlm.nih.gov/pubmed/31040600 http://dx.doi.org/10.4103/UA.UA_111_18